Cargando…

A response to “Mucocutaneous disease and related clinical characteristics in hospitalized children and adolescents with COVID-19 and multisystem inflammatory syndrome in children’’

Detalles Bibliográficos
Autor principal:	Sert, Ahmet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the American Academy of Dermatology, Inc. 2021
Materias:	JAAD Online
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930730/ https://www.ncbi.nlm.nih.gov/pubmed/33677002 http://dx.doi.org/10.1016/j.jaad.2021.02.076

Ejemplares similares

Mucocutaneous disease and related clinical characteristics in hospitalized children and adolescents with COVID-19 and multisystem inflammatory syndrome in children
por: Rekhtman, Sergey, et al.
Publicado: (2021)

COVID-19 vaccination in patients with immune-mediated inflammatory diseases receiving rituximab: A personalized regimen should be formulated
por: Yang, Qian, et al.
Publicado: (2022)

Comment on “Androgenetic alopecia present in the majority of patients hospitalized with COVID-19”
por: Bukovac, Domen, et al.
Publicado: (2021)

In response to: “Reply to research letter”
por: Wan, Marilyn T., et al.
Publicado: (2020)

A glossary of pandemic-related terms
por: Norton, Benjamin B., et al.
Publicado: (2021)

Reply to: “Comment on ‘Androgenetic alopecia present in the majority of patients hospitalized with COVID-19’”
por: Wambier, Carlos G.
Publicado: (2021)

Response to: “Commentary on ‘Role of phototherapy in the era of biologics’”
por: Torres, Angeli Eloise, et al.
Publicado: (2021)

Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign
por: Wambier, Carlos Gustavo, et al.
Publicado: (2020)

Response to: “Applying to dermatology residency during the COVID-19 pandemic”
por: Alia, Erisa, et al.
Publicado: (2021)

Telemedicine for inpatient dermatology consultations in response to the COVID-19 pandemic
por: Trinidad, John, et al.
Publicado: (2020)

Diagnosis of stress-associated dermatologic conditions in New York City safety-net hospitals during the COVID-19 pandemic
por: Tefft, Kristy R., et al.
Publicado: (2022)

The novel application of a tourniquet for reducing medical device–related pressure on the ears
por: Zhao, Xiaodan, et al.
Publicado: (2022)

Invited response to the comment on “Dermatology residents and the care of COVID-19 patients”
por: Grant-Kels, Jane M.
Publicado: (2020)

Response to: “Successful implementation of phototherapy guidelines during the COVID-19 pandemic”
por: Lim, Henry W., et al.
Publicado: (2021)

Absence of specific cutaneous manifestations of severe acute respiratory syndrome coronavirus 2 in a reference center in Brazil
por: Avancini, Joao, et al.
Publicado: (2021)

Response to comment on “Psoriasis and COVID-19: A bidirectional Mendelian randomization study”
por: Chalitsios, Christos V., et al.
Publicado: (2023)

The use of Janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
por: Peterson, Danielle, et al.
Publicado: (2020)

Reply to: “Characterization of acute acro-ischemic lesions in non-hospitalized patients: A case series of 132 patients during the COVID-19 outbreak”
por: Ruggiero, Giuseppe, et al.
Publicado: (2020)

Comment on “Characterization of acute acro-ischemic lesions in non-hospitalized patients: A case series of 132 patients during the COVID-19 outbreak”
por: Fernandez-Nieto, Diego, et al.
Publicado: (2020)

A response to “Male balding is a major risk factor for severe COVID-19”
por: Thatiparthi, Akshitha, et al.
Publicado: (2021)

Sexual transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A new possible route of infection?
por: Patrì, Angela, et al.
Publicado: (2020)

Response to comment on “An evidence-based guide to SARS-Cov-2 vaccination of patients on immunotherapies in dermatology.”
por: Gresham, Louise M., et al.
Publicado: (2021)

Reply to letter to the editor: “A response to ‘Male balding is a major risk factor for severe COVID-19’”
por: Yousaf, Ahmed, et al.
Publicado: (2021)

Response to: “Comment on ‘The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries’”
por: Freeman, Esther E., et al.
Publicado: (2021)

Comment on: “To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out. Characterization of herpetic lesions in hospitalized COVID-19 patients”
por: Fernandez-Nieto, Diego, et al.
Publicado: (2020)

Response to McMahon et al's “Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of four hundred fourteen cases”
por: Poulas, Konstantinos, et al.
Publicado: (2022)

Clinical considerations in pediatric cases of monkeypox
por: Khanna, Urmi, et al.
Publicado: (2023)

Response to: “Reply to ‘Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients’: To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out”
por: Marzano, Angelo Valerio, et al.
Publicado: (2020)

Early-onset effluvium secondary to COVID-19: Clinical and histologic characterization
por: Miola, Anna Carolina, et al.
Publicado: (2022)

Trends in teledermatology use during clinic reopening after COVID-19 closures
por: Su, Mack Y., et al.
Publicado: (2021)

Strategic dermatology clinical operations during the coronavirus disease 2019 (COVID-19) pandemic
por: Price, Kyla N., et al.
Publicado: (2020)

Commentary
por: Shin, Daniel B., et al.
Publicado: (2021)

Reply to Letter to the Editor Regarding: “Applying to dermatology residency during the COVID-19 pandemic”
por: Kearns, Donovan G., et al.
Publicado: (2021)

COVID-19 compels closer scrutiny of disparities in dermatology
por: Temiz, Laurie A., et al.
Publicado: (2021)

Comment on “Cling film for mobile phones to prevent cross-infection during the COVID-19 pandemic”
por: Salman, Andac, et al.
Publicado: (2021)

Could antiphospholipid antibodies contribute to coagulopathy in COVID-19?
por: Parodi, Aurora, et al.
Publicado: (2020)

Virtual didactics exchanges to enhance trainee education
por: Shive, Melissa, et al.
Publicado: (2020)

Using cyclosporine in the COVID era: An emergent need for caution
por: Khurana, Ananta, et al.
Publicado: (2020)

Time to revisit the Health Insurance Portability and Accountability Act (HIPAA)? Accelerated telehealth adoption during the COVID-19 pandemic
por: Bhate, Chinmoy, et al.
Publicado: (2020)

Experience in patients with hidradenitis suppurativa and COVID-19 symptoms
por: Galán, José Luis, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4gv081etfsd0l7rq1l5q445s7o